Astria Therapeutics Inks License Agreement With Ichnos Sciences Markets – MarketWatch

Posted on October 11, 2023 by

By Ben Glickman Astria Therapeutics entered a global exclusive license agreement with Ichnos Sciences for an OX40 portfolio to be developed for the potential…

Markets – MarketWatch

Related Posts

Long U.S. dollar now seen as the most crowded trade, but bodes ill for the greenback Markets – MarketWatch

Canada Top Court Rules Environmental-Review System Largely Unconstitutional — Update Markets – MarketWatch

Taoping Shares Slide 7% After Peaking at $2.65 Following YTD Update Markets – MarketWatch